E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/10/2017 in the Prospect News Convertibles Daily.

New Issue: Dermira prices $250 million five-year 3% convertibles, up 30%

By Wendy Van Sickle

Columbus, Ohio, May 10 – Dermira Inc. priced $250 million of 3% convertible senior notes due 2022 with an initial conversion premium of 30%, the company said in a press release late Wednesday evening.

The Rule 144A deal priced in the middle of talk for a 2.75% to 3.25% yield and at the rich end of talk for an initial conversion premium of 25% to 30%.

Leerink Partners and Cowen & Co. are the joint bookrunners.

There is a $37.5 million over-allotment option.

The notes are convertible at the holder’s option into common stock. The conversion price is $35.45 per share, or 28.2079 shares per each $1,000 of notes.

The issue is non-callable for life.

Holders can put the issue in the event of a fundamental change.

Proceeds will be used for working capital, capital expenditures and other general corporate purposes. The Menlo Park, Calif.-based skin condition drug developer may also use some of the funds to expand its business by in-licensing or acquiring product candidates, technologies, compounds, other assets, commercial products or complementary businesses, though there are no current plans to do so.

Issuer:Dermira Inc.
Securities:Convertible senior notes
Amount:$250 million
Greenshoe:$37.5 million
Maturity:May 15, 2022
Bookrunners:Leerink Partners and Cowen & Co.
Coupon:3%
Call options:None
Put option:Upon a fundamental change at par plus accrued interest
Conversion premium:30%
Conversion price:$35.45
Conversion rate:28.2079
Pricing date:May 10
Settlement date:May 16
Distribution:Rule 144A
Talk:2.75% to 3.25% yield, up 25% to 30%
Stock symbol:NASDAQ: DERM
Stock price:$27.27 as of May 10 close
Market capitalization:$1.15 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.